WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
- (medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
- (病気の)治療,療法 / =psychotherapy
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment.
- Puig L1, Strohal R, Fuiman J, Pedersen R, Szumski A, Koenig AS, Robertson D, Drexel H.
- The Journal of dermatological treatment.J Dermatolog Treat.2014 Dec;25(6):470-81. doi: 10.3109/09546634.2013.848260. Epub 2013 Nov 13.
- OBJECTIVE: To assess cardiometabolic biomarkers in patients with psoriasis before and after etanercept treatment.METHODS: Patients with moderate-to-severe plaque psoriasis were randomized to etanercept 50 mg once or twice weekly, double-blinded. Cardiometabolic biomarkers were assessed at baseline
- PMID 24219012
- Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
- Di Costanzo L1, Napolitano M, Patruno C, Cantelli M, Balato N.
- The Journal of dermatological treatment.J Dermatolog Treat.2014 Dec;25(6):489-94. doi: 10.3109/09546634.2013.848259. Epub 2013 Nov 12.
- Acrodermatitis continua of Hallopeau (ACH), also known as dermatitis repens or acrodermatitis perstans, is a rare acropustular eruption, characterized by sterile pustules, paronychia and atrophic skin changes, onychodystrophy and osteolysis of the distal phalanges of the fingers and toes. While some
- PMID 24215490
Japanese Journal
- 田中 良哉
- 産業医科大学雑誌 33(2), 173-181, 2011-06-01
- 全身性エリテマトーデス(SLE)は多臓器障害を特徴とする全身性自己免疫疾患である.自己反応性T細胞やB細胞の活性化とB細胞から産生された自己抗体が形成する免疫複合体の組織沈着による臓器障害が介在する.SLEの治療には明確な指標はないが,Hahnの診断・治療のアルゴリズムでは,重症臓器病変があれば大量ステロイド薬と免疫抑制薬の併用療法の開始が選択される.しかし,これらの薬剤は副作用が多い非特異的治療 …
- NAID 110008670942
- 経験と考察 生物学的製剤投与関節リウマチ患者の人工関節全置換術の安全性についての検討
Related Links
- 1. J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S14-8. Biologic agents in rheumatoid arthritis: an update for managed care professionals. Agarwal SK(1). Author information: (1)Department of Medicine ...
- Key points Tumor necrosis factor (TNF) was the first cytokine to be fully validated as a therapeutic target for rheumatoid arthritis (RA) Combination therapy with an anti-TNF biologic agent plus methotrexate halts ...
Related Pictures
★リンクテーブル★
[★]
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、~剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
[★]
- 関
- care、cure、curing、practice、psychotherapy、regimen、remediation、remedy、therapeutic、treat、treatment、treatment protocol
[★]
- 関
- biol、biological、biologically、biology、biotic、flesh、organism
[★]
- 関
- aged、ageing、aging、year old